Generation and Biological Activities of Oxidized Phospholipids

Abstract

Glycerophospholipids represent a common class of lipids critically important for integrity of cellular membranes. Oxidation of esterified unsaturated fatty acids dramatically changes biological activities of phospholipids. Apart from impairment of their structural function, oxidation makes oxidized phospholipids (OxPLs) markers of "modified-self" type that are recognized by soluble and cell-associated receptors of innate immunity, including scavenger receptors, natural (germ line-encoded) antibodies, and C-reactive protein, thus directing removal of senescent and apoptotic cells or oxidized lipoproteins. In addition, OxPLs acquire novel biological activities not characteristic of their unoxidized precursors, including the ability to regulate innate and adaptive immune responses. Effects of OxPLs described in vitro and in vivo suggest their potential relevance in different pathologies, including atherosclerosis, acute inflammation, lung injury, and many other conditions. This review summarizes current knowledge on the mechanisms of formation, structures, and biological activities of OxPLs. Furthermore, potential applications of OxPLs as disease biomarkers, as well as experimental therapies targeting OxPLs, are described, providing a broad overview of an emerging class of lipid mediators.

The Cardioprotective Role of Naca in the Prevention of Doxorubicin and Trastuzumab Mediated Cardiac Dysfunction

“…142 The dynamic nature and function of cellular phospholipids is dramatically altered when they are exposed to increased levels of superoxides, ultimately rendering them physiologically damaged and responsible for disease progression. 144 Similarly, our findings also showed significant changes in the lipid profiles of hearts that were subject to DOX+TRZ mediated cardiac dysfunction. Female mice treated with DOX or DOX+TRZ had approximately 3-fold to 4-fold increases in the amount of fragmented oxidized phospholipids as compared to saline treated animals at 72 hours post treatment, respectively.…”

Cyclic phosphatidic acid inhibits the secretion of vascular endothelial growth factor from diabetic human coronary artery endothelial cells through peroxisome proliferator-activated receptor gamma

“…PPARγ agonists promote adipocytic differentiation and stimulate the uptake of low-density lipoprotein by macrophages, leading to foam-cell formation in the arterial wall [38]. Considerable evidence suggests that oxidized phospholipids and fatty acids function as deleterious signaling molecules in the context of atherosclerosis lesion formation [39]. We recently determined that the production of cPA inhibits the transcription of PPARγ-target genes that normally drive adipocytic differentiation, lipid accumulation in macrophages, and arterial-wall remodeling; our recent work suggests that the endogenous LPA analog cPA regulates AGP-elicited VEGF secretion 14 cPA is a bona-fide second messenger and a physiological inhibitor of PPARγ [13].…”

Apolipoprotein A-I (apoA-I) and apoA-I mimetic peptides inhibit tumor development in a mouse model of ovarian cancer

“…Reactive oxygen species may be conducive to the vitality of cancer cells and drive signaling transduction pathways, which leads to activation of redox-sensitive transcription factors and genes involved in cancer cell growth, proliferation, and survival (28,29). Because oxidized lipid mediated inflammation appears to be common (30,31), it is not surprising that lipoproteins may be a central modulator/regulator of diseases, including cancer and atherosclerosis, in which inflammation is an important component.…”